Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

137 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of Library of Plans with two daily adaptive strategies for whole bladder radiotherapy.
den Boer D, den Hartogh MD, Kotte ANTJ, van der Voort van Zyp JRN, Noteboom JL, Bol GH, Willigenburg T, Werensteijn-Honingh AM, Jürgenliemk-Schulz IM, van Lier ALHMW, Kroon PS. den Boer D, et al. Phys Imaging Radiat Oncol. 2021 Nov 20;20:82-87. doi: 10.1016/j.phro.2021.11.002. eCollection 2021 Oct. Phys Imaging Radiat Oncol. 2021. PMID: 34849413 Free PMC article.
Brachytherapy training survey among radiation oncology residents in Europe.
Sturdza AE, Stephanides M, Jurgenliemk-Schulz I, Eriksen JG, Benstead K, Hoskin P, Vlad S, Escande A, Corradini S, Knoth J, Westerveld H, Tagliaferri L, Najari-Jamali D, Konat-Baska K, Plesinac V, Tan LT, Nout R, Strnad V, Niehoff P, Pieters BR, Tanderup K, Kamrava M. Sturdza AE, et al. Radiother Oncol. 2022 Dec;177:172-178. doi: 10.1016/j.radonc.2022.10.030. Epub 2022 Oct 31. Radiother Oncol. 2022. PMID: 36328092
Molecular and Clinicopathologic Characterization of Mismatch Repair-Deficient Endometrial Carcinoma Not Related to MLH1 Promoter Hypermethylation.
Kaya M, Post CCB, Tops CM, Nielsen M, Crosbie EJ, Leary A, Mileshkin LR, Han K, Bessette P, de Boer SM, Jürgenliemk-Schulz IM, Lutgens L, Jobsen JJ, Haverkort MAD, Nout RA, Kroep J, Creutzberg CL, Smit VTHBM, Horeweg N, van Wezel T, Bosse T. Kaya M, et al. Among authors: jurgenliemk schulz im. Mod Pathol. 2024 Mar;37(3):100423. doi: 10.1016/j.modpat.2024.100423. Epub 2024 Jan 6. Mod Pathol. 2024. PMID: 38191122 Free article.
Retinoblastoma Protein Loss in p53 Abnormal Endometrial Carcinoma: Histologic and Clinicopathological Correlates.
Serbes ED, Horeweg N, Parra-Herran C, van Rijnsoever R, Jobsen JJ, Jurgenliemk-Schulz I, Kuijsters N, Nout RA, Haverkort MAD, Powell ME, Khaw P, Plante M, Genestie C, Nijman HW, Creutzberg CL, Bosse T, Kramer CJH. Serbes ED, et al. Mod Pathol. 2024 Nov 20;38(3):100660. doi: 10.1016/j.modpat.2024.100660. Online ahead of print. Mod Pathol. 2024. PMID: 39577664 Free article.
Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry.
Vermij L, Jobsen JJ, León-Castillo A, Brinkhuis M, Roothaan S, Powell ME, de Boer SM, Khaw P, Mileshkin LR, Fyles A, Leary A, Genestie C, Jürgenliemk-Schulz IM, Crosbie EJ, Mackay HJ, Nijman HW, Nout RA, Smit VTHBM, Creutzberg CL, Horeweg N, Bosse T; TransPORTEC Consortium. Vermij L, et al. Br J Cancer. 2023 Mar;128(7):1360-1368. doi: 10.1038/s41416-023-02141-0. Epub 2023 Jan 23. Br J Cancer. 2023. PMID: 36690721 Free PMC article.
137 results